Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
about
Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type miceAtomic Structures Suggest Determinants of Transmission Barriers in Mammalian Prion DiseaseBacterial colitis increases susceptibility to oral prion disease.Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic PatientsReview: contribution of transgenic models to understanding human prion disease.Immunomodulation for prion and prion-related diseases.A Chinese Creutzfeldt-Jakob disease patient with E196K mutation in PRNPCould immunomodulation be used to prevent prion diseases?Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.A multicentre audit of single-use surgical instruments (SUSI) for tonsillectomy and adenoidectomyCurrent and future molecular diagnostics for prion diseases.Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?Therapeutic approaches for prion and Alzheimer's diseases.Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivoHuman tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types.Peripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters.Immunotherapy for prion diseases: opportunities and obstacles.Detection of PrPsc in blood from sheep infected with the scrapie and bovine spongiform encephalopathy agents.Transcriptional changes in the brains of cattle orally infected with the bovine spongiform encephalopathy agent precede detection of infectivity.Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.
P2860
Q24651920-98A474D5-8328-4613-860C-A0DC91285E62Q27666974-E5A7FE8B-CB65-4BEC-B720-C037FF61547BQ33655323-CFDB9705-5C95-43CE-88DF-2109B037F3CAQ33724583-1610A341-2541-47FA-AB19-BD6316A11967Q34474868-9585C909-6450-4C77-9027-837ECC3F18EEQ34565644-CFA3B7C8-B74D-45B7-B6B9-F645F2E7B896Q35194934-425E6E3F-DD29-40E0-BBA0-E612252F260EQ35875915-4904F1FD-65C3-4645-8C0D-B717E1F4F3C8Q35960528-0B5875E4-25DE-41CA-B506-4E4A06C25C27Q36238167-6E98E4CF-DE20-4473-8FAF-ED7B8F76BCC0Q36528891-3FC910FF-4132-4B9C-8525-6297DA1E608BQ36638892-50A3F484-FA79-467E-92A1-F37F72101EA5Q36872884-508D6B73-1715-4091-91F6-A9C097A290B7Q37267798-65A22262-AFCB-4B03-95ED-452BB1180DA6Q37415409-204DC656-2A1D-440D-A48B-82B6E09F9E30Q37462678-F9DFDD41-2977-4926-87DF-565C5ED87376Q37693704-08F01009-9C3C-4377-A350-5662C419E18AQ37773260-611DCE18-75FD-41F3-B819-EE2080D35486Q41869692-47E0D68B-C9F4-4BAF-A4D5-7F5AB90265D2Q42546514-39C46A1E-FC3F-44F2-84AE-0A18C3761FC2Q47294251-BE31A744-CD06-4E1C-8871-5F94EB934DB6Q50513577-BADC37E0-268C-4558-BA1A-19611F90A3A3
P2860
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@ast
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@en
type
label
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@ast
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@en
prefLabel
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@ast
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@en
P2860
P356
P1476
Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.
@en
P2093
David A Hilton
P2860
P304
P356
10.1002/PATH.1880
P577
2006-01-01T00:00:00Z